In the last trading session, 9.68 million BioAffinity Technologies Inc (NASDAQ:BIAF) shares changed hands as the company’s beta touched 2.40. With the company’s per share price at $0.21 changed hands at $0.0 or 2.97% during last session, the market valuation stood at $5.77M. BIAF’s last price was a discount, traded about -1323.81% off its 52-week high of $2.99. The share price had its 52-week low at $0.16, which suggests the last value was 23.81% up since then.
BioAffinity Technologies Inc (NASDAQ:BIAF) trade information
Instantly BIAF was in green as seen at the end of in last trading. With action 2.77%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -76.74%, with the 5-day performance at 2.77% in the green. However, in the 30-day time frame, BioAffinity Technologies Inc (NASDAQ:BIAF) is -54.92% down.
BioAffinity Technologies Inc (BIAF) estimates and forecasts
Year-over-year growth is forecast to reach -35.42% down from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 1.21M. 1 analysts are of the opinion that BioAffinity Technologies Inc’s revenue for the current quarter will be 1.32M. The company’s revenue for the corresponding quarters a year ago was 2.4M and 2.35M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -49.70%. The estimates for the next quarter sales put growth at -43.84%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -10.71%. The 2025 estimates are for BioAffinity Technologies Inc earnings to increase by 40.00%.
BIAF Dividends
BioAffinity Technologies Inc is expected to release its next quarterly earnings report in June.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 220.23 shares estimated at $46622.0 under it, the former controlled 1.21% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.38% of the shares, roughly 69.47 shares worth around $14706.0.
